metabolism
Showing 9976 - 10000 of >10,000
Behavior Trial (Behavioral interventions/modifications)
Withdrawn
- Behavior
- Behavioral interventions/modifications
- (no location specified)
Jun 22, 2020
Friedreich Ataxia Trial in Paris (EGb 761 120 mg, Placebo)
Completed
- Friedreich Ataxia
- EGb 761 120 mg
- Placebo
-
Paris, FranceHospital Necker Enfants Malades
Mar 30, 2020
Diabetes Mellitus for Presence of Skin Disorder of Scleredema
Recruiting
- Diabetes Mellitus
- +3 more
-
Pécs, Baranya, HungaryDept. Rheumatology and Immunology, University of Pécs
Apr 6, 2020
Mild Cognitive Impairment, Alzheimer Dementia Trial in Cadiz (Supervised Exercise Programme)
Completed
- Mild Cognitive Impairment
- Alzheimer Dementia
- Supervised Exercise Programme
-
Cadiz, SpainUniversity of Cádiz
Apr 26, 2021
Non Small Cell Lung Cancer, ROS1 Proto Oncogene, Crizotinib Trial in Worldwide (Crizotinib)
Completed
- Non Small Cell Lung Cancer
- +2 more
-
Hefei, Anhui, China
- +43 more
Feb 3, 2021
NSCLC Trial in United States (enzastaurin, pemetrexed, docetaxel)
Completed
- Non-Small Cell Lung Cancer
- enzastaurin
- +3 more
-
Burlington, North Carolina
- +3 more
Apr 20, 2021
CNS Lesion, Blood Brain Barrier Defect Trial in Worldwide (P03277, Gadobenate dimeglumine, MRI)
Completed
- CNS Lesion
- Blood Brain Barrier Defect
- P03277
- +2 more
-
Chicago, Illinois
- +27 more
Oct 4, 2021
Pulmonary Disease, Chronic Obstructive Trial in Poland, Russian Federation, United States (FF/UMEC/VI, Tiotropium,
Completed
- Pulmonary Disease, Chronic Obstructive
- FF/UMEC/VI
- +7 more
-
Andalusia, Alabama
- +71 more
Jul 13, 2021
Hematologic Malignancies, Hypoproliferative Thrombocytopenia Trial in United States (Mirasol platelets (MIR PLTs), Reference
Terminated
- Hematologic Malignancies
- Hypoproliferative Thrombocytopenia
- Mirasol platelets (MIR PLTs)
- Reference platelets (REF PLTs)
-
Washington, District of Columbia
- +9 more
Jul 28, 2021
Iron Deficiency Anemia Secondary to IBD or Gastric Bypass Trial (Injectafer, Ferrous Sulfate tablets)
Completed
- Iron Deficiency Anemia Secondary to IBD or Gastric Bypass
- Injectafer
- Ferrous Sulfate tablets
- (no location specified)
Sep 16, 2020
Peripheral Arterial Diseases Trial in Georgia, Kazakhstan, Russian Federation (Actovegin, Placebo)
NSCLC Trial in Worldwide (Lorlatinib, Crizotinib)
Active, not recruiting
- Carcinoma, Non-Small-Cell Lung
-
Altamonte Springs, Florida
- +164 more
May 27, 2022
Obesity Trial (G-Niib, Placebo)
Not yet recruiting
- Obesity
- G-Niib
- Placebo
- (no location specified)
Aug 10, 2021
Prevention of Postspinal Shivering Trial in Cairo (Magnesium Sulfate 1000 MG)
Completed
- Prevention of Postspinal Shivering
- Magnesium Sulfate 1000 MG
-
Cairo, Elmanial, Egyptanesthesia department at Cairo University
Aug 4, 2020
SLC13A5 Deficiency Natural History Study - Remote Only
Recruiting
- Citrate Transporter Deficiency
- +9 more
-
Palo Alto, CaliforniaLucille Packard Children's Hospital, Stanford University
Dec 22, 2020
Carcinoma, Renal Cell Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506))
Completed
- Carcinoma, Renal Cell
- Regorafenib (Stivarga, BAY73-4506)
-
Los Angeles, California
- +17 more
Jan 27, 2021
Endothelial Function, Blood Pressure, Lipid Metabolism Trial in Esslingen, Berlin (WAK2017, Placebo)
Unknown status
- Endothelial Function
- +2 more
- WAK2017
- Placebo
-
Esslingen, Baden Würtemberg, Germany
- +1 more
Nov 8, 2017
Herpes Simplex Type 2 Trial in Portland, Houston, Seattle (HerpV and QS-21, Placebo)
Completed
- Herpes Simplex Type 2
- HerpV and QS-21
- Placebo
-
Portland, Oregon
- +4 more
Jun 22, 2021
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Squamous Cell Carcinoma of the Head and Neck Trial in Fargo, Sioux Falls (DCA (dichloroacetate), Placebo)
Completed
- Squamous Cell Carcinoma of the Head and Neck
- DCA (dichloroacetate)
- Placebo
-
Fargo, North Dakota
- +1 more
Oct 2, 2020